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Abstract
Th17 cells are known to be involved in several autoimmune or inflammatory diseases. In celiac disease (CD), recent studies
suggest an implication of those cells in disease pathogenesis. We aimed at studying the role of genes relevant for the Th17
immune response in CD susceptibility. A total of 101 single nucleotide polymorphisms (SNPs), mainly selected to cover most
of the variability present in 16 Th17-related genes (IL23R, RORC, IL6R, IL17A, IL17F, CCR6, IL6, JAK2, TNFSF15, IL23A, IL22, STAT3,
TBX21, SOCS3, IL12RB1 and IL17RA), were genotyped in 735 CD patients and 549 ethnically matched healthy controls. Case-
control comparisons for each SNP and for the haplotypes resulting from the SNPs studied in each gene were performed
using chi-square tests. Gene-gene interactions were also evaluated following different methodological approaches. No
significant results emerged after performing the appropriate statistical corrections. Our results seem to discard a relevant
role of Th17 cells on CD risk.
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Introduction
Celiac disease (CD) is an immune related disease mainly
characterized by intestinal inflammation after gluten ingestion in
genetically susceptible individuals. CD has been traditionally
considered a Th1-mediated disease. However, accumulating
evidence about the relevant role of the novel Th17 immune
response in several autoimmune diseases [1] opened the possibility
towards an involvement of this immunological pathway in CD
pathogenesis. These cells seem to be involved in protective
responses against extracellular pathogens but they can contribute
to chronic inflammation and autoimmunity when dysregulated.
Th17 cells develop from naı¨ve CD161+ CD4+ T cells upon
stimulation with particular immunological stimulus, especifically,
transforming growth factor beta (TGF-b), interleukin (IL)-23, IL-
1b or IL-6 [2]. This induces several transcription factors, mainly
the RAR-related orphan receptor C (RORC), which in turn
activates IL-17A and IL-17F transcription, the distinctive effector
cytokines of this subset of T cells. Production of IL-21, IL-22 and
IL-26 also characterizes this specific response, besides the surface
markers C-C chemokine receptor type 6 (CCR6) and IL-23
receptor (IL-23R).
Studies based on murine models of several autoimmune
diseases, as multiple sclerosis (autoimmune encephalomyelitis,
EAE), rheumatoid arthritis (collagen-induced arthritis, CIA) and
inflammatory bowel disease (experimental colitis), provided the
first evidence about a role of Th17 cells in those conditions [3,4].
This idea was later supported by case-control studies, which
associated genetic variants in IL23R with susceptibility to Crohn’s
disease, psoriasis and ankylosing spondylitis [5,6,7]. Nowadays, the
Th17 immune response is considered as a relevant player in
several autoimmune or inflammatory diseases. IL-17 mRNA or
protein have been detected in biological fluids or the specific
affected tissue in several autoimmune disorders [8] and genetic
studies associated genes coding important Th17 related products
with several diseases [9]. In addition, epistasis between IL23R and
other Th17 related genes has been reported: with IL2/IL21 in UC
[10] and with IL17A and IL17RA in Crohn’s disease [11].
In 2008, a putative implication of the Th17 immune response in
CD pathogenesis was suggested from two studies following
different approaches. Our research group detected a significant
association between a genetic polymorphism in the IL23R gene
and CD [12] and Harris et al. found higher production of IL-23
after stimulation of human monocytes derived from CD patients
with peptic fragments of wheat gliadin [13]. Subsequently, genetic
linkage with the IL23R region was observed in Finnish families,
although this result was not replicated in Hungarian pedigrees and
no association with IL23R polymorphisms was observed in
Finnish, Hungarian or Italian CD samples [14]. In addition,
increased expression of several Th17-related cytokines or products
was detected in patients with active CD [15,16] and very recently,
gluten-specific IL-17A-producing cells have been found in the
duodenum of CD patients [17], which supports a role of Th17
cells in CD pathogenesis.
Despite these results observed in CD, the role of the Th17 cells
on this disease is still not well defined. We aimed at shedding more
light upon this issue by performing an extensive genetic study
including many genes coding distinctive cytokines, markers or
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transcription factors involved in the Th17 response. We will
evaluate the individual influence of those genes on CD
susceptibility and also the possible contribution of gene-gene
interactions. Previous genome wide association studies (GWAS)
did not find association with CD susceptibility of any Th17-related
gene [18,19,20] (with exception of the IL2/IL21 locus, also
involved in other processes), but we consider that a different
scenario could emerge with this study: we cover most of the
variability present in the studied genetic regions and we will
evaluate the genetic interactions between the included polymor-
phisms, which has been proved as a valid approach to detect new
susceptibility variants [21,22].
Materials and Methods
Ethics Statement
This study was approved by the ethical committee (CEIC) of the
Hospital Clı´nico San Carlos. Samples were obtained after
obtaining written informed consent.
Subjects
A total of 735 CD patients and 549 ethnically matched healthy
controls were included in the initial study. A second sample set
consisting of 294 CD patients and 475 controls was used for
additional analysis. All these samples correspond to unrelated
Spanish white individuals. CD patients were diagnosed following
the European Society for Paediatric Gastroenterology and
Nutrition (ESPGAN), 97% are positive for HLA-DQ2 and/or
HLA-DQ8. Controls correspond mainly to blood donors and
laboratory staff. CD samples were consecutively collected in two
centres of the same region (Hospital La Paz and Hospital Clı´nico
San Carlos, Madrid) and controls were collected at the Hospital
Clı´nico San Carlos.
Markers and genotyping
We selected genes with a known functional role in the Th17
immune response. Accordingly, sixteen genes were studied: IL23R,
RORC, IL6R, IL17A, IL17F, CCR6, IL6, JAK2, TNFSF15, IL23A,
IL22, STAT3, TBX21, SOCS3, IL12RB1 and IL17RA. For all these
genes except IL6R, JAK2 and STAT3, single nucleotide polymor-
phisms (SNPs) were selected following the ‘‘aggressive tagging’’
option present in the Haploview program with genetic data
downloaded from the HapMap Project (http://hapmap.ncbi.nlm.
nih.gov) (50 kb upstream and downstream of the transcription
initiation site). To increase statistical power, only markers with a
minor allele frequency (MAF).10% were included. In addition,
SNPs located in those genes which code nonsynonymous changes
or were previously associated with some autoimmune disease were
also analysed independently of their MAF. In STAT3 and JAK2,
only two SNPs previously associated with Crohn’s disease, which
share some susceptibility factors with CD, were included: rs744166
and rs10758669, respectively; and in IL6R we studied one
functional polymorphism, rs8192284. SNPs located in IL6 and
IL6R and two SNPs in IL23R, rs11209026 and rs7517847, were
analysed in previous works [12,23], which included most of the
samples initially analysed in this study, but their data were used to
evaluate genetic interactions with other Th17 related genes.
A total of 101 SNPs were initially studied (Table S1). All of them
were genotyped by Veracode technology performed at the
National Genotyping Center (http://www.cegen.org), except
those that failed (rs10494269, rs9395767, rs608137, rs6927645,
rs273506 and rs2241044) and those located in the IL6, IL6R and
TBX21 genes, which were genotyped with specific TaqMan assays.
Two SNPs (rs11209026 and rs7517847, both in the IL23R gene)
were genotyped by those two technologies and identical results
were obtained.
Additional analysis included the study by TaqMan technology
of rs12070470, in the IL23R gene.
Statistical analysis
Deviations from Hardy-Weinberg proportions were assessed in
all the SNPs studied.
A case-control analysis using chi-square tests was performed for
each individual SNP and for the haplotypes resulting from the
SNPs studied in the same genetic region.
Interactions between genes were evaluated following four
different approaches: logistic regression, random forests (RF),
classification and regression trees (CART) and multifactor
dimensionality reduction (MDR).
Results
Three SNPs showed deviation from Hardy-Weinberg propor-
tions and were eliminated from the study: rs2064331 (IL17F),
rs10878804 (IL22) and rs9645406 (RORC).
The comparison of genotypic frequencies between cases and
controls for all the SNPs analysed achieved a nominal significant
value in twelve polymorphisms located in eight different genetic
regions (Table 1). Although none of them withstand Bonferroni
correction, we tried to replicate associations involving SOCS3 and
IL23R using a second sample set. These two genes show the lowest
case-control p-values in the present analysis and additionally some
SNP in those genes showed a nominal significance in previous CD
GWAS [20].
The initial IL23R data analysis also evidenced one haplotype
significantly associated with CD susceptibility (rs4655683-
rs10889667-rs1569922-rs790632-rs7517847-rs10489629-rs7528924-
rs2201841-rs4655530-rs11209026-rs6682033-rs6693831, G-C-C-C-
T-A-G-T-A-G-A-C): 9.2% in CD patients vs. 6.3% in controls
(p=0.0067). For replication purposes, the SNP rs12070470, highly
correlated with that haplotype (r2=1 according to http://hapmap.
ncbi.nlm.nih.gov/) was studied in the second sample set instead of the
12 SNPs initially considered.
Table 1. Genetic polymorphisms which showed a nominal
significant value after case-control comparisons (in decreasing
significance).
GENE SNP GENOTYPE p OR 95% CI
SOCS3 rs4969170 AA 0.0018 0.59 0.42–0.84
IL23R rs7528924 GG 0.0057 2.11 1.19–3.74
TNFSF15 rs17219926 CC 0.0103 1.43 1.08–1.89
IL6 rs2069827 GT+TT 0.016 1.51 1.06–2.14
IL22 rs11611206 AA 0.019 0.39 0.16–0.93
IL23R rs11209026 AG+GG 0.026 1.42 1.03–1.97
RORC rs1521186 AA+AG 0.027 1.31 1.02–1.67
IL22 rs11177131 CT+TT 0.034 0.76 0.58–0.99
IL17A rs8193036 CT+TT 0.034 0.60 0.36–0.99
IL6 rs1800795 CG+CC 0.037 1.26 1.01–1.58
TNFSF15 rs6478108 CT+CC 0.043 0.79 0.63–1.00
CCR6 rs3798315 TT 0.044 4.17 0.90–38.84
ORs are referred to the mutant genotype or carrier of the mutant allele
(specified below ‘‘genotype’’).
doi:10.1371/journal.pone.0031244.t001
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No significant associations involving IL23R were observed in the
replication set. Regarding the SNP rs4969170, in the SOCS3 gene,
a significant association was observed pooling the original and the
replication sets: p = 0.0012 OR=0.64 95% CI 0.49–0.84
(Table 2). Statistical power limitations probably precluded us to
obtain a significant result in the replication set.
No consensus exists as to the best methodology to evaluate
epistasis. Therefore, we used four different statistical methods to
evaluate genetic interactions between all the studied polymor-
phisms located in different genes. We did not find statistically
significant results with any methodological approach.
Discussion
With the development of genome wide association studies
(GWAS), the number of discovered genes involved in CD
susceptibility has highly increased. However, the percentage of
disease heritability explained has not experienced such an
increase. Genetic variants not included in GWAS and genetic
interactions could be underlying some missing heritability. We
bear this in mind when studying the relevance of the Th17
immune response on CD susceptibility. We performed an
extensive case-control study including sixteen genes which code
relevant factors involved in that immune response. Tag SNPs were
selected to cover most of the variability present in each gene, with
exception of IL6R, STAT3 and JAK2. SNPs coding nonsynon-
ymous changes or those previously associated with other
autoimmune diseases were also included in order to increase the
a priori probability of obtaining a significant result. Additionally, we
evaluated the possibility that interactions between the studied
genes were involved in disease susceptibility. Our results seem to
discard a relevant role of Th17 cells on CD risk, since no
significantly associated SNP or gene-gene interaction was
consistently observed, with the only exception of rs4969170,
located in SOCS3, which deserves further research. However,
although SOCS3 is later confirmed, its functional role must be
elucidated, since it is involved in different functional pathways and
it would be expected that more than one Th17 gene was associated
with CD susceptibility, as it has been observed with other Th17-
mediated diseases.
The discovery of the IL-23 cytokine prompted the re-
examination of the dominant Th response in many autoimmune
diseases, primarily in those considered as skewed towards a Th1
phenotype. Studies based on murine models of multiple sclerosis,
rheumatoid arthritis and inflammatory bowel disease related these
conditions with a Th17 response. However, a similar conclusion is
not drawn from GWAS results [24,25,26]. Although several Th17-
related genes have been associated with IBD and RA, the list of
MS susceptibility genes does not suggest a Th17 related etiology.
This intriguing issue is probably far away from being answered.
Nowadays it seems clear that Th immune responses are not
independent and plasticity exists between Th cell subsets. A shift
between Th1 and Th17 can occur during the inflammatory
process and it is possible to speculate that the relative contribution
and the timing of each subset will determine which genes would be
involved in disease risk. Moreover, the cytokine microenvironment
can determine the shift towards a specific immune response. From
this point of view, genetics could not be so relevant if other
compensatory mechanisms exist. This evidence, as previously
suggested, that overlap between autoimmune diseases must be
observed with caution. Th17 cells seem to mediate several
autoimmune diseases but their impact in disease etiology seems
to be different.
In summary, gene expression studies link CD pathogenesis to
Th17 cells, but we evidenced that polymorphisms in Th17-related
genes do not seem to be crucial for disease development. This is
concordant with observations on MS. Although, in general,
genetic data provide clues that ratified by functional studies
unravel disease pathogenesis, this time it makes necessary to do
somehow the other way around, with the special difficulty of
explaining the divergent genetic results observed in different
immune mediated diseases. Therefore, much more work is
expected in this field.
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